Does Novartis Pharmaceuticals Corp sponsor H1B visas?
In the last 5 years (2021–2025), Novartis Pharmaceuticals Corp filed 386 H1B petitions and 373 were approved (96.63% approval rate), per USCIS records. The median wage it offered on 111 certified H1B Labor Condition Applications in FY2025 was $142,771, per U.S. Department of Labor records.
Updated USCIS data through 2025DOL LCA data through
Check any company in one click
Install the free GlanceJobs - H1B OPT Sponsorship Checker extension to see OPT, CPT, and H1B sponsorship status right on LinkedIn, Indeed, Dice, and Glassdoor — no searching required.
Approved petitions, 2021–2025
- 2021
- 2022
- 2023
- 2024
- 2025
| Year | Filed | Approved | Denied | Withdrawn | Approval % |
|---|---|---|---|---|---|
| 2021 | 140 | 134 | 6 | 0 | 95.71% |
| 2022 | 82 | 78 | 4 | 0 | 95.12% |
| 2023 | 31 | 31 | 0 | 0 | 100% |
| 2024 | 53 | 53 | 0 | 0 | 100% |
| 2025 | 80 | 77 | 3 | 0 | 96.25% |
| Total | 386 | 373 | 13 | 0 | 96.63% |
Full history, 2009–2025
995 approved of 1,019 filed across 17 years (97.64% approval rate).
- 2009
- 2010
- 2011
- 2012
- 2013
- 2014
- 2015
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
Show all 17 years in a table
| Year | Filed | Approved | Denied | Withdrawn | Approval % |
|---|---|---|---|---|---|
| 2025 | 80 | 77 | 3 | 0 | 96.25% |
| 2024 | 53 | 53 | 0 | 0 | 100% |
| 2023 | 31 | 31 | 0 | 0 | 100% |
| 2022 | 82 | 78 | 4 | 0 | 95.12% |
| 2021 | 140 | 134 | 6 | 0 | 95.71% |
| 2020 | 76 | 74 | 2 | 0 | 97.37% |
| 2019 | 51 | 49 | 2 | 0 | 96.08% |
| 2018 | 40 | 40 | 0 | 0 | 100% |
| 2017 | 43 | 41 | 2 | 0 | 95.35% |
| 2016 | 47 | 47 | 0 | 0 | 100% |
| 2015 | 38 | 37 | 1 | 0 | 97.37% |
| 2014 | 49 | 47 | 2 | 0 | 95.92% |
| 2013 | 42 | 42 | 0 | 0 | 100% |
| 2012 | 64 | 64 | 0 | 0 | 100% |
| 2011 | 43 | 43 | 0 | 0 | 100% |
| 2010 | 47 | 47 | 0 | 0 | 100% |
| 2009 | 93 | 91 | 2 | 0 | 97.85% |
| Total | 1,019 | 995 | 24 | 0 | 97.64% |
Novartis Pharmaceuticals Corp LCA filings by year
Before an H1B petition, the employer files a Labor Condition Application (LCA) with the Department of Labor. One LCA can cover several workers and not every LCA becomes a petition, so these counts differ from the USCIS petitions above.
LCAs filed by fiscal year
- FY2021
- FY2022
- FY2023
- FY2024
- FY2025
- FY2026through Jun 30
| Fiscal year | LCAs filed | Certified | Certified, then withdrawn | Withdrawn | Denied | Worker positions |
|---|---|---|---|---|---|---|
| FY2026 (through Jun 30) | 75 | 75 | 0 | 0 | 0 | 75 |
| FY2025 | 112 | 112 | 0 | 0 | 0 | 112 |
| FY2024 | 90 | 90 | 0 | 0 | 0 | 90 |
| FY2023 | 95 | 93 | 0 | 2 | 0 | 95 |
| FY2022 | 76 | 76 | 0 | 0 | 0 | 76 |
| FY2021 | 112 | 103 | 8 | 1 | 0 | 112 |
| Total | 560 | 549 | 8 | 3 | 0 | 560 |
H1B LCAs only (not E-3 or H-1B1), by the fiscal year of the Department of Labor decision (October to September). Source: U.S. Department of Labor, Office of Foreign Labor Certification disclosure data.
Tailor your resume to the Novartis Pharmaceuticals Corp job description.
Paste the job description. GlanceJobs AI tailors your resume to it and drafts the cover letter. Sign up and get 1 month of Pro free.
What Novartis Pharmaceuticals Corp offers H1B workers
Wages Novartis Pharmaceuticals Corp offered on 111 certified, full-time H1B Labor Condition Applications, per U.S. Department of Labor records.
Median and middle 50% by year
- FY2021$118K$92K–$137K
- FY2022$124K$104K–$143K
- FY2023$128K$99K–$154K
- FY2024$136K$114K–$163K
- FY2025$143K$125K–$170K
- FY2026 through Jun 30$144K$113K–$170K
| Job title | Filings | Median | Middle 50% |
|---|---|---|---|
| Principal Biostatistician | 10 | $112,965 | $113K–$113K |
| Senior Principal Biostatistician | 4 | $120,412 | $113K–$132K |
| Expert Science & Technology | 3 | $112,757 | $104K–$118K |
Where these roles are, FY2025
- East Hanover, NJ94 filings$144K median
- Cambridge, MA10 filings$113K median
- Morris Plains, NJ4 filings$103K median
- Durham, NC2 filings
- Santa Clara, CA1 filings
H1B salaries by job title at Novartis Pharmaceuticals Corp
These are wages offered on the Labor Condition Application (Form ETA-9035), annualized, not salaries actually paid. Certified full-time H1B filings only. Fiscal years run October to September. Source: U.S. Department of Labor, Office of Foreign Labor Certification disclosure data.
Other healthcare employers that sponsor H1B
Common questions about Novartis Pharmaceuticals Corp
Does Novartis Pharmaceuticals Corp sponsor H1B visas?
Yes. Novartis Pharmaceuticals Corp had 373 H1B petitions approved in the last 5 years (2021–2025) and 995 across 2009–2025, most recently in 2025, per USCIS records.
What is Novartis Pharmaceuticals Corp's H1B approval rate?
96.63% of the 386 H1B petitions Novartis Pharmaceuticals Corp filed in 2021–2025 were approved. 13 were denied and 0 were withdrawn. Across 2009–2025 the approval rate is 97.64%.
How many H1B petitions did Novartis Pharmaceuticals Corp file in 2025?
80 petitions, of which 77 were approved (96.25% approval rate).
Which year did Novartis Pharmaceuticals Corp have the most H1B approvals?
2021, with 134 approved H1B petitions.
How many H1B Labor Condition Applications did Novartis Pharmaceuticals Corp file in fiscal year 2025?
112 LCAs covering 112 worker positions: 112 certified, 0 certified then withdrawn, 0 withdrawn and 0 denied, per U.S. Department of Labor records. An LCA is filed before the H1B petition, so this differs from the USCIS petition count.
How much does Novartis Pharmaceuticals Corp pay H1B workers?
The median wage Novartis Pharmaceuticals Corp offered on its 111 certified, full-time H1B Labor Condition Applications in fiscal year 2025 was $142,771, with the middle half of offers between $125,164 and $170,373, per U.S. Department of Labor records.
Does Novartis Pharmaceuticals Corp hire students on OPT?
Yes. Novartis Pharmaceuticals Corp is listed as an OPT employer in the GlanceJobs employer index.